MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, BCAB had -$41,928K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$41,928K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from ppas
    • Accounts payable and accrued exp...
    • Prepaid expenses and other asset...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Payment of financing costs relat...
    • Change in fair value of warrant ...
    • Payments for taxes related to ne...

Cash Flow
2025-12-31
Net loss
-59,607
Depreciation and amortization
373
Loss on disposal of property and equipment
-185
Change in fair value of warrant liability
-295
Change in fair value of ppas liability
406
Commitment fee under sepa
282
Financing costs related to ppas
742
Stock-based compensation
5,434
Prepaid expenses and other assets
-1,128
Accounts payable and accrued expenses
2,804
Right-of-use assets and lease liabilities, net
344
Net cash used in operating activities
-48,204
Proceeds from ppas
7,125
Payment of financing costs related to issuance of common stock, ppas and sepa
897
Proceeds from issuance of common stock and warrants, net of issuance costs
0
Proceeds from issuance of common stock under employee stock purchase plan
100
Payments for taxes related to net settlement of equity awards
52
Net cash provided by financing activities
6,276
Net decrease in cash and cash equivalents
-41,928
Cash and cash equivalents, beginning of period
49,046
Cash and cash equivalents, end of period
7,118
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from ppas$7,125K Proceeds from issuance ofcommon stock under...$100K Net cash provided byfinancing activities$6,276K Canceled cashflow$949K Net decrease in cashand cash...-$41,928K Canceled cashflow$6,276K Stock-based compensation$5,434K Accounts payable andaccrued expenses$2,804K Prepaid expenses andother assets-$1,128K Financing costs related toppas$742K Change in fair value ofppas liability$406K Depreciation andamortization$373K Right-of-use assets and leaseliabilities, net$344K Commitment fee under sepa$282K Loss on disposal ofproperty and equipment-$185K Payment of financingcosts related to...$897K Payments for taxesrelated to net...$52K Net cash used inoperating activities-$48,204K Canceled cashflow$11,698K Net loss-$59,607K Change in fair value ofwarrant liability-$295K

BioAtla, Inc. (BCAB)

BioAtla, Inc. (BCAB)